A型肝炎ワクチンのグローバル市場2021

• 英文タイトル：Global Hepatitis A Vaccine Sales Market Report 2021

• レポートコード：QAF24761
• 出版社/出版日：QYResearch / 2021年4月5日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、132ページ
• 納品方法：Eメール（即日納品）
• 産業分類：食品＆飲料

• 販売価格（消費税別）

Single User	￥600,000 (USD4,000)	▷ お問い合わせ
Multi User	￥900,000 (USD6,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本市場調査資料では、世界のA型肝炎ワクチン市場について種類別（不活化ワクチン、弱毒生ワクチン）、用途別（政府機関、民間部門、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・A型肝炎ワクチン市場の概要
・世界の主要地域別A型肝炎ワクチン市場規模2016-2027
・主要プレイヤーの競争状況・市場シェア
・世界のA型肝炎ワクチン市場規模2016-2021：種類別（不活化ワクチン、弱毒生ワクチン）
・世界のA型肝炎ワクチン市場予測2012-2027：種類別（不活化ワクチン、弱毒生ワクチン）
・世界のA型肝炎ワクチン市場規模2016-2021：用途別（政府機関、民間部門、その他）
・世界のA型肝炎ワクチン市場予測2012-2027：用途別（政府機関、民間部門、その他）
・A型肝炎ワクチンのアメリカ市場規模と予測2016-2021
・A型肝炎ワクチンのヨーロッパ市場規模と予測2016-2021
・A型肝炎ワクチンの中国市場規模と予測2016-2021
・A型肝炎ワクチンの日本市場規模と予測2016-2021
・A型肝炎ワクチンの東南アジア市場規模と予測2016-2021
・A型肝炎ワクチンのインド市場規模と予測2016-2021
・主要プレイヤーの企業情報：事業概要・売上・企業動向
（GSK、Merck、Sanofi、Sinovac、Zhejiang Pukang、Changchun Institute of Biological、KM Biologics、IMBCA、ChangSheng、Convac）
・A型肝炎ワクチンの製造コスト分析
・販売チャネル、流通業者、顧客
・A型肝炎ワクチンの市場動向・機会・課題
・調査の結論

Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.

Two types of HAV vaccines are currently available internationally:

1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).

2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.

Market Analysis and Insights: Global Hepatitis A Vaccine Market
The global Hepatitis A Vaccine market was valued at US$ 706.9 in 2020 and will reach US$ 800.8 million by the end of 2027, growing at a CAGR of 2.1% during 2022-2027.

Global Hepatitis A Vaccine Scope and Market Size
The global Hepatitis A Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hepatitis A Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Inactivated Vaccine
Live Attenuated Vaccine

Segment by Application
Government Institution
Private Sector
Other

The Hepatitis A Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Hepatitis A Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCA
ChangSheng
Convac

レポート目次

1 Hepatitis A Vaccine Market Overview
1.1 Hepatitis A Vaccine Product Scope
1.2 Hepatitis A Vaccine Segment by Type
1.2.1 Global Hepatitis A Vaccine Sales by Type (2016 & 2021 & 2027)
1.2.2 Inactivated Vaccine
1.2.3 Live Attenuated Vaccine
1.3 Hepatitis A Vaccine Segment by Application
1.3.1 Global Hepatitis A Vaccine Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Hepatitis A Vaccine Market Estimates and Forecasts (2016-2027)
1.4.1 Global Hepatitis A Vaccine Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Hepatitis A Vaccine Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Hepatitis A Vaccine Price Trends (2016-2027)

2 Hepatitis A Vaccine Estimates and Forecasts by Region
2.1 Global Hepatitis A Vaccine Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Hepatitis A Vaccine Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Hepatitis A Vaccine Sales Market Share by Region (2016-2021)
2.2.2 Global Hepatitis A Vaccine Revenue Market Share by Region (2016-2021)
2.3 Global Hepatitis A Vaccine Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Hepatitis A Vaccine Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Hepatitis A Vaccine Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Hepatitis A Vaccine Estimates and Projections (2016-2027)
2.4.2 Europe Hepatitis A Vaccine Estimates and Projections (2016-2027)
2.4.3 China Hepatitis A Vaccine Estimates and Projections (2016-2027)
2.4.4 Japan Hepatitis A Vaccine Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Hepatitis A Vaccine Estimates and Projections (2016-2027)
2.4.6 India Hepatitis A Vaccine Estimates and Projections (2016-2027)
3 Global Hepatitis A Vaccine Competition Landscape by Players
3.1 Global Top Hepatitis A Vaccine Players by Sales (2016-2021)
3.2 Global Top Hepatitis A Vaccine Players by Revenue (2016-2021)
3.3 Global Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hepatitis A Vaccine as of 2020)
3.4 Global Hepatitis A Vaccine Average Price by Company (2016-2021)
3.5 Manufacturers Hepatitis A Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Hepatitis A Vaccine Market Size by Type
4.1 Global Hepatitis A Vaccine Historic Market Review by Type (2016-2021)
4.1.1 Global Hepatitis A Vaccine Sales Market Share by Type (2016-2021)
4.1.2 Global Hepatitis A Vaccine Revenue Market Share by Type (2016-2021)
4.1.3 Global Hepatitis A Vaccine Price by Type (2016-2021)
4.2 Global Hepatitis A Vaccine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Hepatitis A Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Hepatitis A Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Global Hepatitis A Vaccine Price Forecast by Type (2022-2027)
5 Global Hepatitis A Vaccine Market Size by Application
5.1 Global Hepatitis A Vaccine Historic Market Review by Application (2016-2021)
5.1.1 Global Hepatitis A Vaccine Sales Market Share by Application (2016-2021)
5.1.2 Global Hepatitis A Vaccine Revenue Market Share by Application (2016-2021)
5.1.3 Global Hepatitis A Vaccine Price by Application (2016-2021)
5.2 Global Hepatitis A Vaccine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Hepatitis A Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Hepatitis A Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Hepatitis A Vaccine Price Forecast by Application (2022-2027)

6 North America Hepatitis A Vaccine Market Facts & Figures
6.1 North America Hepatitis A Vaccine Sales by Company
6.1.1 North America Hepatitis A Vaccine Sales by Company (2016-2021)
6.1.2 North America Hepatitis A Vaccine Revenue by Company (2016-2021)
6.2 North America Hepatitis A Vaccine Sales Breakdown by Type
6.2.1 North America Hepatitis A Vaccine Sales Breakdown by Type (2016-2021)
6.2.2 North America Hepatitis A Vaccine Sales Breakdown by Type (2022-2027)
6.3 North America Hepatitis A Vaccine Sales Breakdown by Application
6.3.1 North America Hepatitis A Vaccine Sales Breakdown by Application (2016-2021)
6.3.2 North America Hepatitis A Vaccine Sales Breakdown by Application (2022-2027)

7 Europe Hepatitis A Vaccine Market Facts & Figures
7.1 Europe Hepatitis A Vaccine Sales by Company
7.1.1 Europe Hepatitis A Vaccine Sales by Company (2016-2021)
7.1.2 Europe Hepatitis A Vaccine Revenue by Company (2016-2021)
7.2 Europe Hepatitis A Vaccine Sales Breakdown by Type
7.2.1 Europe Hepatitis A Vaccine Sales Breakdown by Type (2016-2021)
7.2.2 Europe Hepatitis A Vaccine Sales Breakdown by Type (2022-2027)
7.3 Europe Hepatitis A Vaccine Sales Breakdown by Application
7.3.1 Europe 132 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 132 Sales Breakdown by Application (2022-2027)

8 China Hepatitis A Vaccine Market Facts & Figures
8.1 China Hepatitis A Vaccine Sales by Company
8.1.1 China Hepatitis A Vaccine Sales by Company (2016-2021)
8.1.2 China Hepatitis A Vaccine Revenue by Company (2016-2021)
8.2 China Hepatitis A Vaccine Sales Breakdown by Type
8.2.1 China Hepatitis A Vaccine Sales Breakdown by Type (2016-2021)
8.2.2 China Hepatitis A Vaccine Sales Breakdown by Type (2022-2027)
8.3 China Hepatitis A Vaccine Sales Breakdown by Application
8.3.1 China 246 Sales Breakdown by Application (2016-2021)
8.3.2 China 246 Sales Breakdown by Application (2022-2027)

9 Japan Hepatitis A Vaccine Market Facts & Figures
9.1 Japan Hepatitis A Vaccine Sales by Company
9.1.1 Japan Hepatitis A Vaccine Sales by Company (2016-2021)
9.1.2 Japan Hepatitis A Vaccine Revenue by Company (2016-2021)
9.2 Japan Hepatitis A Vaccine Sales Breakdown by Type
9.2.1 Japan Hepatitis A Vaccine Sales Breakdown by Type (2016-2021)
9.2.2 Japan Hepatitis A Vaccine Sales Breakdown by Type (2022-2027)
9.3 Japan Hepatitis A Vaccine Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Hepatitis A Vaccine Market Facts & Figures
10.1 Southeast Asia Hepatitis A Vaccine Sales by Company
10.1.1 Southeast Asia Hepatitis A Vaccine Sales by Company (2016-2021)
10.1.2 Southeast Asia Hepatitis A Vaccine Revenue by Company (2016-2021)
10.2 Southeast Asia Hepatitis A Vaccine Sales Breakdown by Type
10.2.1 Southeast Asia Hepatitis A Vaccine Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Hepatitis A Vaccine Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Hepatitis A Vaccine Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)

11 India Hepatitis A Vaccine Market Facts & Figures
11.1 India Hepatitis A Vaccine Sales by Company
11.1.1 India Hepatitis A Vaccine Sales by Company (2016-2021)
11.1.2 India Hepatitis A Vaccine Revenue by Company (2016-2021)
11.2 India Hepatitis A Vaccine Sales Breakdown by Type
11.2.1 India Hepatitis A Vaccine Sales Breakdown by Type (2016-2021)
11.2.2 India Hepatitis A Vaccine Sales Breakdown by Type (2022-2027)
11.3 India Hepatitis A Vaccine Sales Breakdown by Application
11.3.1 India Hepatitis A Vaccine Sales Breakdown by Application (2016-2021)
11.3.2 India Hepatitis A Vaccine Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Hepatitis A Vaccine Business
12.1 GSK
12.1.1 GSK Corporation Information
12.1.2 GSK Business Overview
12.1.3 GSK Hepatitis A Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GSK Hepatitis A Vaccine Products Offered
12.1.5 GSK Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Business Overview
12.2.3 Merck Hepatitis A Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Merck Hepatitis A Vaccine Products Offered
12.2.5 Merck Recent Development
12.3 Sanofi
12.3.1 Sanofi Corporation Information
12.3.2 Sanofi Business Overview
12.3.3 Sanofi Hepatitis A Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sanofi Hepatitis A Vaccine Products Offered
12.3.5 Sanofi Recent Development
12.4 Sinovac
12.4.1 Sinovac Corporation Information
12.4.2 Sinovac Business Overview
12.4.3 Sinovac Hepatitis A Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sinovac Hepatitis A Vaccine Products Offered
12.4.5 Sinovac Recent Development
12.5 Zhejiang Pukang
12.5.1 Zhejiang Pukang Corporation Information
12.5.2 Zhejiang Pukang Business Overview
12.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Zhejiang Pukang Hepatitis A Vaccine Products Offered
12.5.5 Zhejiang Pukang Recent Development
12.6 Changchun Institute of Biological
12.6.1 Changchun Institute of Biological Corporation Information
12.6.2 Changchun Institute of Biological Business Overview
12.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Changchun Institute of Biological Hepatitis A Vaccine Products Offered
12.6.5 Changchun Institute of Biological Recent Development
12.7 KM Biologics
12.7.1 KM Biologics Corporation Information
12.7.2 KM Biologics Business Overview
12.7.3 KM Biologics Hepatitis A Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 KM Biologics Hepatitis A Vaccine Products Offered
12.7.5 KM Biologics Recent Development
12.8 IMBCA
12.8.1 IMBCA Corporation Information
12.8.2 IMBCA Business Overview
12.8.3 IMBCA Hepatitis A Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 IMBCA Hepatitis A Vaccine Products Offered
12.8.5 IMBCA Recent Development
12.9 ChangSheng
12.9.1 ChangSheng Corporation Information
12.9.2 ChangSheng Business Overview
12.9.3 ChangSheng Hepatitis A Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 ChangSheng Hepatitis A Vaccine Products Offered
12.9.5 ChangSheng Recent Development
12.10 Convac
12.10.1 Convac Corporation Information
12.10.2 Convac Business Overview
12.10.3 Convac Hepatitis A Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Convac Hepatitis A Vaccine Products Offered
12.10.5 Convac Recent Development

13 Hepatitis A Vaccine Manufacturing Cost Analysis
13.1 Hepatitis A Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Hepatitis A Vaccine
13.4 Hepatitis A Vaccine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Hepatitis A Vaccine Distributors List
14.3 Hepatitis A Vaccine Customers

15 Market Dynamics
15.1 Hepatitis A Vaccine Market Trends
15.2 Hepatitis A Vaccine Drivers
15.3 Hepatitis A Vaccine Market Challenges
15.4 Hepatitis A Vaccine Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Hepatitis A Vaccine Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Hepatitis A Vaccine Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Hepatitis A Vaccine Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Hepatitis A Vaccine Sales (K MT) by Region (2016-2021)
Table 5. Global Hepatitis A Vaccine Sales Market Share by Region (2016-2021)
Table 6. Global Hepatitis A Vaccine Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Hepatitis A Vaccine Revenue Share by Region (2016-2021)
Table 8. Global Hepatitis A Vaccine Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Hepatitis A Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Hepatitis A Vaccine Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Hepatitis A Vaccine Revenue Share Forecast by Region (2022-2027)
Table 12. Global Hepatitis A Vaccine Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Hepatitis A Vaccine Sales Share by Company (2016-2021)
Table 14. Global Hepatitis A Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Hepatitis A Vaccine Revenue Share by Company (2016-2021)
Table 16. Global Hepatitis A Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis A Vaccine as of 2020)
Table 17. Global Hepatitis A Vaccine Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Hepatitis A Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Hepatitis A Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Hepatitis A Vaccine Sales (K MT) by Type (2016-2021)
Table 22. Global Hepatitis A Vaccine Sales Share by Type (2016-2021)
Table 23. Global Hepatitis A Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Hepatitis A Vaccine Price (USD/MT) by Type (2016-2021)
Table 25. Global Hepatitis A Vaccine Sales Share by Type (2022-2027)
Table 26. Global Hepatitis A Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Hepatitis A Vaccine Revenue Share by Type (2022-2027)
Table 28. Global Hepatitis A Vaccine Price (USD/MT) by Type (2022-2027)
Table 29. Global Hepatitis A Vaccine Sales (K MT) by Application (2016-2021)
Table 30. Global Hepatitis A Vaccine Sales Share by Application (2016-2021)
Table 31. Global Hepatitis A Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Hepatitis A Vaccine Price (USD/MT) by Application (2016-2021)
Table 33. Global Hepatitis A Vaccine Sales (K MT) by Application (2022-2027)
Table 34. Global Hepatitis A Vaccine Sales Share by Application (2022-2027)
Table 35. Global Hepatitis A Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Hepatitis A Vaccine Revenue Share by Application (2022-2027)
Table 37. Global Hepatitis A Vaccine Price (USD/MT) by Application (2022-2027)
Table 38. North America Hepatitis A Vaccine Sales (K MT) by Company (2016-2021)
Table 39. North America Hepatitis A Vaccine Sales Market Share by Company (2016-2021)
Table 40. North America Hepatitis A Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Hepatitis A Vaccine Revenue Market Share by Company (2016-2021)
Table 42. North America Hepatitis A Vaccine Sales by Type (2016-2021) & (K MT)
Table 43. North America Hepatitis A Vaccine Sales Market Share by Type (2016-2021)
Table 44. North America Hepatitis A Vaccine Sales by Type (2022-2027) & (K MT)
Table 45. North America Hepatitis A Vaccine Sales Market Share by Type (2022-2027)
Table 46. North America Hepatitis A Vaccine Sales by Application (2016-2021) & (K MT)
Table 47. North America Hepatitis A Vaccine Sales Market Share by Application (2016-2021)
Table 48. North America Hepatitis A Vaccine Sales by Application (2022-2027) & (K MT)
Table 49. North America Hepatitis A Vaccine Sales Market Share by Application (2022-2027)
Table 50. Europe Hepatitis A Vaccine Sales (K MT) by Company (2016-2021)
Table 51. Europe Hepatitis A Vaccine Sales Market Share by Company (2016-2021)
Table 52. Europe Hepatitis A Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Hepatitis A Vaccine Revenue Market Share by Company (2016-2021)
Table 54. Europe Hepatitis A Vaccine Sales by Type (2016-2021) & (K MT)
Table 55. Europe Hepatitis A Vaccine Sales Market Share by Type (2016-2021)
Table 56. Europe Hepatitis A Vaccine Sales by Type (2022-2027) & (K MT)
Table 57. Europe Hepatitis A Vaccine Sales Market Share by Type (2022-2027)
Table 58. Europe Hepatitis A Vaccine Sales by Application (2016-2021) & (K MT)
Table 59. Europe Hepatitis A Vaccine Sales Market Share by Application (2016-2021)
Table 60. Europe Hepatitis A Vaccine Sales by Application (2022-2027) & (K MT)
Table 61. Europe Hepatitis A Vaccine Sales Market Share by Application (2022-2027)
Table 62. China Hepatitis A Vaccine Sales (K MT) by Company (2016-2021)
Table 63. China Hepatitis A Vaccine Sales Market Share by Company (2016-2021)
Table 64. China Hepatitis A Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Hepatitis A Vaccine Revenue Market Share by Company (2016-2021)
Table 66. China Hepatitis A Vaccine Sales by Type (2016-2021) & (K MT)
Table 67. China Hepatitis A Vaccine Sales Market Share by Type (2016-2021)
Table 68. China Hepatitis A Vaccine Sales by Type (2022-2027) & (K MT)
Table 69. China Hepatitis A Vaccine Sales Market Share by Type (2022-2027)
Table 70. China Hepatitis A Vaccine Sales by Application (2016-2021) & (K MT)
Table 71. China Hepatitis A Vaccine Sales Market Share by Application (2016-2021)
Table 72. China Hepatitis A Vaccine Sales by Application (2022-2027) & (K MT)
Table 73. China Hepatitis A Vaccine Sales Market Share by Application (2022-2027)
Table 74. Japan Hepatitis A Vaccine Sales (K MT) by Company (2016-2021)
Table 75. Japan Hepatitis A Vaccine Sales Market Share by Company (2016-2021)
Table 76. Japan Hepatitis A Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Hepatitis A Vaccine Revenue Market Share by Company (2016-2021)
Table 78. Japan Hepatitis A Vaccine Sales by Type (2016-2021) & (K MT)
Table 79. Japan Hepatitis A Vaccine Sales Market Share by Type (2016-2021)
Table 80. Japan Hepatitis A Vaccine Sales by Type (2022-2027) & (K MT)
Table 81. Japan Hepatitis A Vaccine Sales Market Share by Type (2022-2027)
Table 82. Japan Hepatitis A Vaccine Sales by Application (2016-2021) & (K MT)
Table 83. Japan Hepatitis A Vaccine Sales Market Share by Application (2016-2021)
Table 84. Japan Hepatitis A Vaccine Sales by Application (2022-2027) & (K MT)
Table 85. Japan Hepatitis A Vaccine Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Hepatitis A Vaccine Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Hepatitis A Vaccine Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Hepatitis A Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Hepatitis A Vaccine Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Hepatitis A Vaccine Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Hepatitis A Vaccine Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Hepatitis A Vaccine Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Hepatitis A Vaccine Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Hepatitis A Vaccine Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Hepatitis A Vaccine Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Hepatitis A Vaccine Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Hepatitis A Vaccine Sales Market Share by Application (2022-2027)
Table 98. India Hepatitis A Vaccine Sales (K MT) by Company (2016-2021)
Table 99. India Hepatitis A Vaccine Sales Market Share by Company (2016-2021)
Table 100. India Hepatitis A Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Hepatitis A Vaccine Revenue Market Share by Company (2016-2021)
Table 102. India Hepatitis A Vaccine Sales by Type (2016-2021) & (K MT)
Table 103. India Hepatitis A Vaccine Sales Market Share by Type (2016-2021)
Table 104. India Hepatitis A Vaccine Sales by Type (2022-2027) & (K MT)
Table 105. India Hepatitis A Vaccine Sales Market Share by Type (2022-2027)
Table 106. India Hepatitis A Vaccine Sales by Application (2016-2021) & (K MT)
Table 107. India Hepatitis A Vaccine Sales Market Share by Application (2016-2021)
Table 108. India Hepatitis A Vaccine Sales by Application (2022-2027) & (K MT)
Table 109. India Hepatitis A Vaccine Sales Market Share by Application (2022-2027)
Table 110. GSK Corporation Information
Table 111. GSK Description and Business Overview
Table 112. GSK Hepatitis A Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. GSK Hepatitis A Vaccine Product
Table 114. GSK Recent Development
Table 115. Merck Corporation Information
Table 116. Merck Description and Business Overview
Table 117. Merck Hepatitis A Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Merck Hepatitis A Vaccine Product
Table 119. Merck Recent Development
Table 120. Sanofi Corporation Information
Table 121. Sanofi Description and Business Overview
Table 122. Sanofi Hepatitis A Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Sanofi Hepatitis A Vaccine Product
Table 124. Sanofi Recent Development
Table 125. Sinovac Corporation Information
Table 126. Sinovac Description and Business Overview
Table 127. Sinovac Hepatitis A Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Sinovac Hepatitis A Vaccine Product
Table 129. Sinovac Recent Development
Table 130. Zhejiang Pukang Corporation Information
Table 131. Zhejiang Pukang Description and Business Overview
Table 132. Zhejiang Pukang Hepatitis A Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. Zhejiang Pukang Hepatitis A Vaccine Product
Table 134. Zhejiang Pukang Recent Development
Table 135. Changchun Institute of Biological Corporation Information
Table 136. Changchun Institute of Biological Description and Business Overview
Table 137. Changchun Institute of Biological Hepatitis A Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Changchun Institute of Biological Hepatitis A Vaccine Product
Table 139. Changchun Institute of Biological Recent Development
Table 140. KM Biologics Corporation Information
Table 141. KM Biologics Description and Business Overview
Table 142. KM Biologics Hepatitis A Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. KM Biologics Hepatitis A Vaccine Product
Table 144. KM Biologics Recent Development
Table 145. IMBCA Corporation Information
Table 146. IMBCA Hepatitis A Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. IMBCA Description and Business Overview
Table 148. IMBCA Hepatitis A Vaccine Product
Table 149. IMBCA Recent Development
Table 150. ChangSheng Corporation Information
Table 151. ChangSheng Hepatitis A Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. ChangSheng Description and Business Overview
Table 153. ChangSheng Hepatitis A Vaccine Product
Table 154. ChangSheng Recent Development
Table 155. Convac Corporation Information
Table 156. Convac Description and Business Overview
Table 157. Convac Hepatitis A Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 158. Convac Hepatitis A Vaccine Product
Table 159. Convac Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. Hepatitis A Vaccine Distributors List
Table 163. Hepatitis A Vaccine Customers List
Table 164. Hepatitis A Vaccine Market Trends
Table 165. Hepatitis A Vaccine Market Drivers
Table 166. Hepatitis A Vaccine Market Challenges
Table 167. Hepatitis A Vaccine Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Hepatitis A Vaccine Product Picture
Figure 2. Global Hepatitis A Vaccine Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Hepatitis A Vaccine Sales Market Share by Application in 2021 & 2027
Figure 6. Government Institution Examples
Figure 7. Private Sector Examples
Figure 8. Other Examples
Figure 9. Global Hepatitis A Vaccine Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Hepatitis A Vaccine Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Hepatitis A Vaccine Sales (K MT) Growth Rate (2016-2027)
Figure 12. Global Hepatitis A Vaccine Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 13. Global Hepatitis A Vaccine Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Hepatitis A Vaccine Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Hepatitis A Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Hepatitis A Vaccine Sales (K MT) Growth Rate (2016-2027)
Figure 17. Europe Hepatitis A Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Hepatitis A Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Hepatitis A Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Hepatitis A Vaccine Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Hepatitis A Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Hepatitis A Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Hepatitis A Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Hepatitis A Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Hepatitis A Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Hepatitis A Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Hepatitis A Vaccine Players Market Share by Revenue in Hepatitis A Vaccine: 2016 & 2020
Figure 28. Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Hepatitis A Vaccine Revenue Share by Type (2016-2021)
Figure 30. Global Hepatitis A Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Hepatitis A Vaccine Revenue Share by Application (2016-2021)
Figure 32. Global Hepatitis A Vaccine Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Hepatitis A Vaccine Sales Market Share by Type in 2020
Figure 34. North America Hepatitis A Vaccine Sales Market Share by Application in 2020
Figure 35. Europe Hepatitis A Vaccine Sales Market Share by Type in 2020
Figure 36. Europe Hepatitis A Vaccine Sales Market Share by Application in 2020
Figure 37. China Hepatitis A Vaccine Sales Market Share by Type in 2020
Figure 38. China Hepatitis A Vaccine Sales Market Share by Application in 2020
Figure 39. Japan Hepatitis A Vaccine Sales Market Share by Type in 2020
Figure 40. Japan Hepatitis A Vaccine Sales Market Share by Application in 2020
Figure 41. Southeast Asia Hepatitis A Vaccine Sales Market Share by Type in 2020
Figure 42. Southeast Asia Hepatitis A Vaccine Sales Market Share by Application in 2020
Figure 43. India Hepatitis A Vaccine Sales Market Share by Type in 2020
Figure 44. India Hepatitis A Vaccine Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Hepatitis A Vaccine
Figure 47. Manufacturing Process Analysis of Hepatitis A Vaccine
Figure 48. Hepatitis A Vaccine Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed

以下、関連資料のご紹介

人用ワクチンのグローバル市場2021

Global Human Vaccine Sales Market Report 2021
QAF27724 2021年4月20日 149Pages
本市場調査資料では、世界の人用ワクチン市場について種類別（水痘、インフルエンザ、ポリオ、A型肝炎、狂犬病、BCG、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌、ロタワクチン）、用途別（大人用、子供用）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。20...

魚類ワクチンのグローバル市場2021

Global Fish Vaccine Sales Market Report 2021
QAF27688 2021年4月26日 134Pages
本市場調査資料では、世界の魚類ワクチン市場について種類別（注射用ワクチン、ディップワクチン、経口ワクチン）、用途別（パンガシウス、ティラピア、サーモン、シーバス、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模...

インフルエンザワクチンのグローバル市場2021

Global Influenza Vaccine Sales Market Report 2021
QAF27737 2021年4月22日 139Pages
本市場調査資料では、世界のインフルエンザワクチン市場について種類別（全ウイルスワクチン、分割ウイルスワクチン、サブユニットワクチン、弱毒生ウイルスワクチン）、用途別（子供用（6ヶ月～3歳）、大人用、3歳以上子供用）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏め...

ポリオワクチンのグローバル市場2021

Global Polio Vaccine Sales Market Report 2021
QAF27852 2021年4月9日 132Pages
本市場調査資料では、世界のポリオワクチン市場について種類別（不活化ポリオワクチン（IPV）、経口ポリオワクチン（OPV））、用途別（公共用、個人用）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、...

狂犬病ワクチンのグローバル市場2021

Global Rabies Vaccine Sales Market Report 2021
QAF27867 2021年4月1日 137Pages
本市場調査資料では、世界の狂犬病ワクチン市場について種類別（ベロ細胞狂犬病ワクチン、BHK、ひよこ胚細胞狂犬病ワクチン、その他）、用途別（暴露前予防、暴露後予防）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（...

世界のアルコール性肝炎治療市場規模・現状・予測（2021年-2027年）

Global Alcoholic Hepatitis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3776 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、アルコール性肝炎治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、キサンチン誘導体、その他）、用途別市場規模（病院、診療所、私立治療センター）、主要地域別市場規模（北米、アメリカ...

ペプチドがんワクチンのグローバル市場2021

Global Peptide Cancer Vaccine Sales Market Report 2021
QAF27830 2021年4月9日 146Pages
本市場調査資料では、世界のペプチドがんワクチン市場について種類別（アメリカ、ヨーロッパ、日本、中国、南米、その他）、用途別（乳がん、肺がん、黒色腫、前立腺がん、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と...

世界のB型肝炎治療薬市場規模・現状・予測（2021年-2027年）

Global Hepatitis B Drug Market Size, Status and Forecast 2021-2027
QFJ1-5776 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、B型肝炎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エンテカビル、テノホビル、ラミブジン、アデフォビル、テルビブジン、その他）、用途別市場規模（病院薬局、小売薬局＆ドラッグストア、その他）、...

世界のB型肝炎診断検査市場規模・現状・予測（2021年-2027年）

Global Hepatitis B Diagnostic Tests Market Size, Status and Forecast 2021-2027
QFJ1-4302 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、B型肝炎診断検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（酵素免疫測定キット、ポイントオブケア検査キット）、用途別市場規模（病院、診療所、診断センター、ホームケア）、主要地域別市場規模（北米、ア...

水痘弱毒生ワクチンのグローバル市場2021

Global Varicella Attenuated Live Vaccine Sales Market Report 2021
QAF27925 2021年3月24日 130Pages
本市場調査資料では、世界の水痘弱毒生ワクチン市場について種類別（一価ワクチン、混合ワクチン）、用途別（子供用注射、大人用注射）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤー...

水痘弱毒生ワクチンのグローバル市場2021 A live attenuated varicella vaccine, derived from the Oka strain of VZV has clinical efficacy for the prevention of varicella. For the major players of Varicella Attenuated Live Vaccine, Merck maintained its first place in the ranking in 2019, followed by BCHT, Shanghai Institute, GSK and Keygen. To…
人用ワクチンのグローバル市場2021 A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. China …
世界の水産養殖用ワクチン市場規模・現状・予測（2021年-2027年） It is a biological preparation that improves immunity to a particular disease work on aquaculture. Market Analysis and Insights: Global Aquaculture Vaccine Market The global Aquaculture Vaccine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% du…
インフルエンザワクチンのグローバル市場2021 Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 6…
世界の髄膜炎菌感染症ワクチン市場規模・現状・予測（2021年-2027年） Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitidis.Different versions are effective against some or all of the following types of meningococcus: A, C, W-135,and Y.The vaccines are between 85 and 100% effective for at least two years.They result in…